NYSE:BDXMedical Equipment
The Bull Case For Becton Dickinson (BDX) Could Change Following New Biopsy System Clearance And Syringe Expansion
Becton, Dickinson and Company recently received FDA 510(k) clearance for its EnCor EnCompass Breast Biopsy and Tissue Removal System, while also committing US$110.00 million to expand BD Neopak Glass Prefillable Syringe production in Columbus, Nebraska to support biologic and GLP-1 drug delivery.
These moves broaden BD’s breast health and pharmaceutical systems portfolios, tying clinical diagnostics innovation directly to reshoring and strengthening of the U.S. drug delivery supply...